Systematic ReviewSystematic Review
Open Access

Venous thromboembolism in COVID-19

A meta-summary of cases

Naif Saad ALGhasab, Leen A. Altamimi, Mohammed Salem Alharbi, Sulaman S. ALMesned and Aditya K. Khetan
Saudi Medical Journal September 2022, 43 (9) 979-990; DOI: https://doi.org/10.15537/smj.2022.43.9.20220316

References

  1. 1.↵
    1. Majumder J,
    2. Minko T.
    Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J 2021; 23: 14.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Li J,
    2. Huang DQ,
    3. Zou B,
    4. Yng H,
    5. Hui WZ,
    6. Rui F, et al.
    Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol 2021; 93: 1449–1458.
    OpenUrlPubMed
  3. 3.↵
    1. Wolff D,
    2. Nee S,
    3. Hickey NS,
    4. Marschollek M.
    Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021; 49: 15–28.
    OpenUrlPubMed
  4. 4.↵
    1. Dou Q,
    2. Wei X,
    3. Zhou K,
    4. Yang S,
    5. Jia P.
    Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020; 31: 893–904.
    OpenUrl
  5. 5.↵
    1. Pan LY,
    2. Zhang WW,
    3. Cheng F,
    4. Hu SS,
    5. Zhang X,
    6. Jiang HY.
    A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19. Int J Infect Dis 2020; 100: 34–41.
    OpenUrlCrossRef
  6. 6.↵
    1. Di Minno A,
    2. Ambrosino P,
    3. Calcaterra I,
    4. Di Minno MN.
    COVID-19 and venous thromboembolism: a meta-analysis of literature studies. Semin Thromb Hemost 2020; 46: 763–771.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Walid A.
    Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders. SAGE Open Med 2021; 9: 20503121211002996.
    OpenUrl
  8. 8.↵
    1. Mazzeffi MA,
    2. Chow JH,
    3. Tanaka K.
    COVID-19 Associated hypercoagulability: manifestations, mechanisms, and management. Shock 2021; 55: 465–471.
    OpenUrlPubMed
  9. 9.↵
    1. Davis, Kenyani
    . COVID-19 pneumonia with back pain: Presentation of an acute pulmonary embolism associated with novel coronavirus infection in an outpatient setting. Clinical Case Reports 2020; 8: 2514–2517.
    OpenUrl
  10. 10.↵
    1. Aoi S,
    2. Kakkar AM,
    3. Golowa Y,
    4. Grushko M,
    5. Coyle CM,
    6. Elrafei T, et al.
    Saddle pulmonary embolism and clot in transit in COVID-19 infection: a case report of catastrophic venous thromboembolism. Eur Heart J Case Rep 2020; 4: 1–6.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Brüggemann R,
    2. Gietema H,
    3. Jallah B,
    4. Ten Cate H,
    5. Stehouwer C,
    6. Spaetgens B.
    Arterial and venous thromboembolic disease in a patient with COVID-19: A case report. Thromb Res 2020; 191: 153–155.
    OpenUrlPubMed
  12. 12.
    1. Colombo L,
    2. Macheda A,
    3. Gentile D,
    4. Panizzardi F,
    5. Pierini S,
    6. Codazzi C, et al.
    How to manage thromboembolic risk in patient with SARS-CoV-2-related disease in the Emergency Department: A case report of cardiogenic shock due to massive pulmonary embolism. Respir Med Case Rep 2003; 31: 101185.
    OpenUrl
  13. 13.
    1. Delcros Q,
    2. Rohmer J,
    3. Tcherakian C,
    4. Groh M.
    Extensive DVT and pulmonary embolism leading to the diagnosis of coronavirus disease 2019 in the absence of severe acute respiratory syndrome coronavirus 2 pneumonia. Chest 2020; 158: e269–e271.
    OpenUrl
  14. 14.↵
    1. Fiorini NB,
    2. Garagoli F,
    3. Bustamante RC,
    4. Pizarro R.
    Acute pulmonary embolism in a patient with mild COVID-19 symptoms: a case report. Eur Heart J Case Rep 2021; 5; ytaa563.
    OpenUrl
  15. 15.↵
    1. Maryam HB,
    2. Abbas F,
    3. Hafeez W. A
    46-year-old woman who presented with diabetic ketoacidosis and COVID-19 pneumonia with multiple pulmonary thromboemboli: A case report. Am J Case Rep 2020; 21: e925794-1–e925794-4,
    OpenUrl
  16. 16.
    1. Sushma K,
    2. Ashraf HM,
    3. Minkowitz S,
    4. Adeyinka A,
    5. Bailey-Correa K.
    COVID-19 infection and acute pulmonary embolism in an adolescent female with sickle cell disease. Cureus 2020; 12: e12348.
    OpenUrl
  17. 17.
    1. Mene-Afejuku TO,
    2. Jeyashanmugaraja GP,
    3. Akinlonu AA,
    4. Osman M,
    5. Hoq M.
    Venous thromboembolism has a variable time of occurrence in the course of COVID-19: A case series. Cureus 2020; 12: e12295.
    OpenUrl
  18. 18.
    1. Akel T,
    2. Qaqa F,
    3. Abuarqoub A,
    4. Shamoon F.
    Pulmonary embolism: A complication of COVID 19 infection. Thromb Res 2020; 193: 79–82.
    OpenUrl
  19. 19.↵
    1. Fortuzi K,
    2. Ghazanfar H,
    3. Haider A,
    4. Patel K,
    5. Patel M.
    Pulmonary embolism in COVID-19 pneumonia: Random association or causality? Cureus 2020; 12: e8900.
    OpenUrl
  20. 20.↵
    1. Kanso M,
    2. Cardi T,
    3. Marzak H,
    4. Schatz A,
    5. Faucher L,
    6. Grunebaum L, et al.
    Delayed pulmonary embolism after COVID-19 pneumonia: a case report. Eur Heart J Case Rep 2020; 4: 1–4.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Paul L,
    2. Tharp JL.
    Breakthrough venous thromboembolic events in five patients with COVID-19 on direct oral anticoagulants. J Clin Pharm Ther 2021; 46: 519–523.
    OpenUrl
  22. 22.
    1. Gaurav M,
    2. Gupta M,
    3. Congrete S,
    4. Datta D.
    Submassive pulmonary embolism in mild COVID-19 without lung infiltrates. Cureus 2021; 13; e13978.
    OpenUrl
  23. 23.
    1. Onkarappa Mangala Y,
    2. Daid SS,
    3. Lakshmanan S,
    4. Kapil R,
    5. Miskovsky J.
    Acute pulmonary embolism in COVID-19: A report of two cases. Cureu 2020; 12:e9459.
    OpenUrl
  24. 24.↵
    1. Mathew N,
    2. Shi D,
    3. Gordon M,
    4. Chavda Y,
    5. Grimaldi C,
    6. Bajaj T.
    Where there’s smoke, there’s fire: A case report of turbulent blood flow in lower extremity point-of-care ultrasound in COVID-19. Clinical practice and cases in emergency medicine 2021; 5: 30–34.
    OpenUrl
  25. 25.↵
    1. Overstad S,
    2. Tjonnfjord E,
    3. Garabet L,
    4. Fronas S,
    5. Bergan J,
    6. Aballi S, et al.
    Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases. Thromb Res 2020; 194: 116–118.
    OpenUrl
  26. 26.↵
    1. Sakr Y,
    2. Giovini M,
    3. Leone M,
    4. Pizzilli G,
    5. Kortgen A,
    6. Bauer M.
    The clinical spectrum of pulmonary thromboembolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A European case series. J Crit Care2021; 61: 39–44.
    OpenUrlCrossRef
  27. 27.↵
    1. Salam S,
    2. Mallat J,
    3. Elkambergy H.
    Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis. Respir Med Case Rep 2020; 31: 101263.
    OpenUrl
  28. 28.↵
    1. Sethi SS,
    2. Zilinyi R,
    3. Green P,
    4. Eisenberger A,
    5. Brodie D,
    6. Agerstrand C, et al.
    Right ventricular clot in transit in COVID-19: Implications for the pulmonary embolism response team. JACC Case Rep 2020; 2: 1391–1396.
    OpenUrlPubMed
  29. 29.
    1. Singh G,
    2. Bin Attique H,
    3. Gadela NV,
    4. Mapara K,
    5. Manickaratnam S.
    COVID-19 Related arterial coagulopathy. Cureus 2020; 12: e9490.
    OpenUrl
  30. 30.↵
    1. Uppuluri EM,
    2. Shapiro NL.
    Development of pulmonary embolism in a nonhospitalized patient with COVID-19 who did not receive venous thromboembolism prophylaxis. Am J Health Syst Pharm 2020; 23: 1957–1960.
    OpenUrl
  31. 31.↵
    1. Mumoli N,
    2. Dentali F,
    3. Conte G,
    4. Colombo A,
    5. Capra R,
    6. Porta C, et al.
    Upper extremity deep vein thrombosis in COVID-19: incidence and correlated risk factors in a cohort of non-ICU patients. PLoS One 2022; 17: e0262522.
    OpenUrl
  32. 32.↵
    1. Tang N,
    2. Li D,
    3. Wang X,
    4. Sun Z.
    Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18: 844–847.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Suh YJ,
    2. Hong H,
    3. Ohana M,
    4. Bompard F,
    5. Revel MP,
    6. Valle C, et al.
    Pulmonary embolism and deep vein thrombosis in COVID-19: A systematic review and meta-analysis. Radiology 2021; 298: E70–E80.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Riyahi S,
    2. Hectors SJ,
    3. Prince MR,
    4. Sweeney EM,
    5. Lane EG,
    6. Honya R, et al.
    Predictors of acute deep venous thrombosis in patients hospitalized for COVID-19. Medicine (Baltimore) 2021; 100: e27216.
    OpenUrl
  35. 35.↵
    1. Hariri LP,
    2. North CM,
    3. Shih AR,
    4. Isreal RA,
    5. Maley JH,
    6. Villalba JA, et al.
    Lung histopathology in COVID-19 as compared to SARS and H1N1 influenza: a systematic review. Chest 2021; 159: 73–84.
    OpenUrl
  36. 36.↵
    1. Mumoli N,
    2. Conte G,
    3. Cei M,
    4. Vitale J,
    5. Capra R,
    6. Rotiroti G, et al.
    In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis. Thromb Res 2021; 203: 82–84.
    OpenUrl
  37. 37.↵
    1. Gerotziafas GT,
    2. Catalano M,
    3. Colgan MP,
    4. Pecsvarady Z,
    5. Wautrecht JC,
    6. Fazeli B, et al.
    Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: Position paper from vas-european independent foundation in angiology/vascular medicine. Thrombosis and haemostasis 2020; 120: 1597–1628.
    OpenUrlCrossRefPubMed
  38. 38.↵
    National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing COVID-19. [Updated 2022 Jly 14; accessed 2022 March 9]. Available from: https://www.nice.org.uk/guidance/ng191/chapter/Recommendations
  39. 39.↵
    1. Hozayen SM,
    2. Zychowski D,
    3. Benson S,
    4. Lutsey PL,
    5. Haslbauer J,
    6. Tzankovet A, et al.
    Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients. EClinicalMedicine 2021; 41: 101139.
    OpenUrl
  40. 40.↵
    1. Asakura H,
    2. Ogawa H.
    COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol 2021; 113: 45–57.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Smadja DM,
    2. Bonnet G,
    3. Gendron N,
    4. Weizman O,
    5. Khider L,
    6. Trimaille A, et al.
    Intermediate- vs. standard-dose prophylactic anticoagulation in patients with COVID-19 admitted in medical ward: A propensity score-matched cohort study. Front Med (Lausanne) 2021; 8: 747527.
    OpenUrl
  42. 42.↵
    1. Rivera-Caravaca JM,
    2. Buckley BJ,
    3. Harrison SL,
    4. Fazio-Eynullayeva E,
    5. Underhill P,
    6. Marín F, et al.
    Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes. Thromb Res 2021; 205: 1–7.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords